These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1780327)

  • 1. Effect of octreotide, a long-acting somatostatin analogue, on plasma amino acid uptake by the pancreas.
    Gullo L; Pezzilli R; Ancona D; Labate AM; Barbara L
    Pancreas; 1991 Nov; 6(6):668-72. PubMed ID: 1780327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pancreatic polypeptide, thyrotropin-releasing hormone, and glucagon on plasma amino acid uptake by human pancreas.
    Gullo L
    Gastroenterology; 1991 Apr; 100(4):1095-9. PubMed ID: 1900491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatostatin on plasma amino acid uptake by human pancreas.
    Gullo L; Pezzilli R; Barbara L
    Gastroenterology; 1989 Sep; 97(3):732-6. PubMed ID: 2568964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201-995).
    Kemmer TP; Malfertheiner P; Büchler M; Friess H; Meschenmoser L; Ditschuneit H
    Aliment Pharmacol Ther; 1992 Feb; 6(1):41-50. PubMed ID: 1371938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin analogues and exocrine pancreatic secretion.
    Gullo L
    Digestion; 1996; 57 Suppl 1():93. PubMed ID: 8813482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma amino acid consumption and pancreatic secretion during and after cerulein-induced pancreatitis in rats.
    Fischer H; Konturek JW; Szlachcic A; Konturek SJ; Domschke W
    Int J Pancreatol; 1995 Oct; 18(2):127-34. PubMed ID: 8530828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a new somatostatin analogue on pancreatic function in healthy volunteers.
    Köhler E; Beglinger C; Dettwiler S; Whitehouse I; Gyr K
    Pancreas; 1986; 1(2):154-9. PubMed ID: 2437563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pancreatic secretion under long-term octreotide treatment in humans.
    Friess H; Bordihn K; Ebert M; Malfertheiner P; Kemmer T; Dennler HJ; Büchler MW
    Digestion; 1994; 55 Suppl 1():10-5. PubMed ID: 8132133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of octreotide (SMS 201-995) on meal-stimulated pancreatic secretion in three patients with external pancreatic fistula.
    Gullo L; Biliotti G; Pezzilli R; Di Stefano M; Ancona D
    Am J Gastroenterol; 1991 Jul; 86(7):892-4. PubMed ID: 2058634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat pancreas after long-term treatment with the somatostatin analogue octreotide.
    von Schönfeld J; Meisse F; Müller MK
    Exp Physiol; 1995 Nov; 80(6):1031-8. PubMed ID: 8962703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin (CCK) in the amino acid uptake and enzyme protein secretion by the pancreas in humans.
    Konturek JW; Gabryelewicz A; Kulesza E; Konturek SJ; Domschke W
    Int J Pancreatol; 1995 Feb; 17(1):55-61. PubMed ID: 8568335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
    Shiratori K; Watanabe S; Takeuchi T
    Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
    Harris AG
    Gut; 1994; 35(3 Suppl):S1-4. PubMed ID: 7911441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does somatostatin analogue prevent experimental acute pancreatitis?
    Murayama KM; Drew JB; Joehl RJ
    Arch Surg; 1990 Dec; 125(12):1570-2. PubMed ID: 2244811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prolonged administration of long-acting somatostatin on caerulein, CCK-8 and GRP induced pancreatic growth in the rat.
    Hajri A; Aprahamian M; Damgé C
    Regul Pept; 1991 Feb; 32(2):227-37. PubMed ID: 1709749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous observation of endocrine and exocrine functions of the pancreas responding to somatostatin in man.
    Emoto T; Miyata M; Izukura M; Yumiba T; Mizutani S; Sakamoto T; Matsuda H
    Regul Pept; 1997 Jan; 68(1):1-8. PubMed ID: 9094748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the thyroid on exocrine pancreatic function.
    Gullo L; Pezzilli R; Bellanova B; D'Ambrosi A; Alvisi V; Barbara L
    Gastroenterology; 1991 May; 100(5 Pt 1):1392-6. PubMed ID: 2013384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pharmacological effects of SMS 201-995 on gastric secretion.
    Gyr KE; Whitehouse I; Beglinger C; Köhler E; Dettwiler S; Fried M
    Scand J Gastroenterol Suppl; 1986; 119():96-102. PubMed ID: 2876511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pancreastatin on cerulein-stimulated pancreatic blood flow and exocrine secretion in anaesthetized rats.
    Migita Y; Nakano I; Goto M; Ito T; Nawata H
    J Gastroenterol Hepatol; 1999 Jun; 14(6):583-7. PubMed ID: 10385069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of SMS 201-995 on exocrine pancreatic secretion in a patient with external pancreatic fistula.
    Ohta T; Nagakawa T; Mori K; Kanno M; Kayahara M; Ueno K; Miyazaki I
    Int J Pancreatol; 1992 Jun; 11(3):185-9. PubMed ID: 1517658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.